secwatch.observer — SEC 8-K summary
======================================

Issuer:     HAEMONETICS CORP (HAE)
CIK:        0000313143
Form:       8-K
Filed at:   2026-02-05T23:59:59+00:00
Accession:  0000313143-26-000009
Event type: earnings
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Haemonetics reports Q3 results; specifics not available from provided text
--------------------------------------------------------------------------

- Press release dated February 5, 2026, furnished as Exhibit 99.1 for Q3 and nine months ended December 27, 2025.
- No financial figures were included in the available filing content for analysis.
- Markets rely on full press release details for revenue, EPS, and segment performance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/313143/000031314326000009/0000313143-26-000009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/313143/000031314326000009/hae-20260205.htm
  HTML page:      https://secwatch.observer/filing/0000313143-26-000009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer